Gilman Hill Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5M | Buy |
63,879
+14,083
| +28% | +$1.14M | 0.68% | 61 |
|
|
2026
Q1 | $4.31M | Buy |
49,796
+2,886
| +6% | +$276K | 0.65% | 65 |
|
|
2025
Q4 | $4.51M | Buy |
46,910
+3,707
| +9% | +$360K | 0.71% | 67 |
|
|
2025
Q3 | $4.11M | Buy |
43,203
+255
| +0.6% | +$23.4K | 0.64% | 69 |
|
|
2025
Q2 | $3.74M | Buy |
42,948
+246
| +0.6% | +$20.9K | 0.61% | 68 |
|
|
2025
Q1 | $3.84M | Buy |
42,702
+778
| +2% | +$69.6K | 0.67% | 60 |
|
|
2024
Q4 | $3.35M | Buy |
41,924
+1,016
| +2% | +$88K | 0.58% | 66 |
|
|
2024
Q3 | $3.68M | Sell |
40,908
-1,159
| -3% | -$97.5K | 0.62% | 64 |
|
|
2024
Q2 | $3.31M | Buy |
42,067
+2,709
| +7% | +$222K | 0.6% | 68 |
|
|
2024
Q1 | $3.43M | Buy |
39,358
+151
| +0.4% | +$12.9K | 0.62% | 63 |
|
|
2023
Q4 | $3.23M | Sell |
39,207
-172
| -0.4% | -$13.1K | 0.6% | 59 |
|
|
2023
Q3 | $3.09M | Buy |
39,379
+1,555
| +4% | +$130K | 0.61% | 62 |
|
|
2023
Q2 | $3.33M | Buy |
37,824
+585
| +2% | +$50.4K | 0.62% | 59 |
|
|
2023
Q1 | $3M | Buy |
37,239
+18,790
| +102% | +$1.53M | 0.61% | 62 |
|
|
2022
Q4 | $1.43M | Buy |
18,449
+2,770
| +18% | +$225K | 0.29% | 93 |
|
|
2022
Q3 | $1.27M | Buy |
15,679
+534
| +4% | +$48K | 0.3% | 96 |
|
|
2022
Q2 | $1.36M | Sell |
15,145
-257
| -2% | -$26K | 0.29% | 92 |
|
|
2022
Q1 | $1.71M | Buy |
15,402
+1,169
| +8% | +$124K | 0.39% | 78 |
|
|
2021
Q4 | $1.47M | Buy |
14,233
+1,142
| +9% | +$132K | 0.33% | 85 |
|
|
2021
Q3 | $1.64M | Buy |
13,091
+315
| +2% | +$40.8K | 0.42% | 70 |
|
|
2021
Q2 | $1.59M | Buy |
12,776
+5,359
| +72% | +$673K | 0.41% | 74 |
|
|
2021
Q1 | $876K | Buy |
7,417
+375
| +5% | +$44K | 0.24% | 94 |
|
|
2020
Q4 | $825K | Buy |
7,042
+540
| +8% | +$59.4K | 0.27% | 92 |
|
|
2020
Q3 | $676K | Sell |
6,502
-80
| -1% | -$8.03K | 0.26% | 92 |
|
|
2020
Q2 | $604K | Buy |
6,582
+300
| +5% | +$28.8K | 0.24% | 96 |
|
|
2020
Q1 | $567K | Sell |
6,282
-100
| -2% | -$10.6K | 0.27% | 97 |
|
|
2019
Q4 | $724K | Sell |
6,382
-245
| -4% | -$26.9K | 0.24% | 102 |
|
|
2019
Q3 | $720K | Sell |
6,627
-20
| -0.3% | -$2.09K | 0.24% | 97 |
|
|
2019
Q2 | $647K | Sell |
6,647
-1,105
| -14% | -$101K | 0.22% | 104 |
|
|
2019
Q1 | $706K | Sell |
7,752
-210
| -3% | -$18.8K | 0.25% | 97 |
|
|
2018
Q4 | $724K | Sell |
7,962
-3,407
| -30% | -$318K | 0.3% | 83 |
|
|
2018
Q3 | $1.12M | Sell |
11,369
-130
| -1% | -$12K | 0.44% | 61 |
|
|
2018
Q2 | $984K | Buy |
11,499
+50
| +0.4% | +$4.18K | 0.4% | 64 |
|
|
2018
Q1 | $918K | Buy |
11,449
+595
| +5% | +$49.1K | 0.4% | 64 |
|
|
2017
Q4 | $876K | Buy |
10,854
+65
| +0.6% | +$5.21K | 0.36% | 66 |
|
|
2017
Q3 | $839K | Buy |
10,789
+1,464
| +16% | +$122K | 0.34% | 71 |
|
|
2017
Q2 | $828K | Buy |
9,325
+1,790
| +24% | +$151K | 0.36% | 65 |
|
|
2017
Q1 | $607K | Buy |
7,535
+215
| +3% | +$16.8K | 0.26% | 84 |
|
|
2016
Q4 | $521K | Buy |
7,320
+2,060
| +39% | +$162K | 0.19% | 101 |
|
|
2016
Q3 | $454K | Buy |
5,260
+190
| +4% | +$16.6K | 0.18% | 105 |
|
|
2016
Q2 | $440K | Sell |
5,070
-95
| -2% | -$7.68K | 0.18% | 99 |
|
|
2016
Q1 | $387K | Buy |
5,165
+145
| +3% | +$10.9K | 0.18% | 111 |
|
|
2015
Q4 | $386K | Buy |
5,020
+895
| +22% | +$67.4K | 0.19% | 107 |
|
|
2015
Q3 | $276K | Buy |
4,125
+424
| +11% | +$31.2K | 0.14% | 120 |
|
|
2015
Q2 | $274K | Buy |
+3,701
| New | +$283K | 0.13% | 133 |
|
Other funds holding MDT
Gilman Hill Asset Management's MDT Position: Q2 2026 in Review
Gilman Hill Asset Management increased its Medtronic (MDT) stake by 28% in Q2 2026, buying an estimated $1.14M and bringing the position to 63,879 shares worth $5M. The position accounts for 0.68% of the portfolio, ranked #61.
Gilman Hill Asset Management first reported a position in MDT in Q2 2015 and has held it in 45 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Gilman Hill Asset Management held 63,879 shares of Medtronic worth $5M as of Q2 2026.
- Gilman Hill Asset Management bought 14,083 Medtronic shares in Q2 2026, an estimated $1.14M.
- Medtronic made up 0.68% of Gilman Hill Asset Management's portfolio in Q2 2026, its #61 holding.
- Gilman Hill Asset Management first reported a position in Medtronic in Q2 2015 and has held it in 45 quarters since.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.